HomeCompareMMC vs JNJ

MMC vs JNJ: Dividend Comparison 2026

MMC yields 1.97% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MMC wins by $6.40M in total portfolio value
10 years
MMC
MMC
● Live price
1.97%
Share price
$182.70
Annual div
$3.60
5Y div CAGR
85.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.43M
Annual income
$5,337,816.49
Full MMC calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — MMC vs JNJ

📍 MMC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMMCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MMC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MMC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MMC
Annual income on $10K today (after 15% tax)
$167.49/yr
After 10yr DRIP, annual income (after tax)
$4,537,144.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, MMC beats the other by $4,533,158.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MMC + JNJ for your $10,000?

MMC: 50%JNJ: 50%
100% JNJ50/50100% MMC
Portfolio after 10yr
$3.23M
Annual income
$2,671,252.95/yr
Blended yield
82.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MMC
Analyst Ratings
8
Buy
17
Hold
1
Sell
Consensus: Hold
Price Target
$211.10
+15.5% upside vs current
Range: $190.00 — $257.00
Altman Z
2.1
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MMC buys
0
JNJ buys
0
No recent congressional trades found for MMC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMMCJNJ
Forward yield1.97%2.13%
Annual dividend / share$3.60$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR85.7%28%
Portfolio after 10y$6.43M$30.3K
Annual income after 10y$5,337,816.49$4,689.40
Total dividends collected$6.32M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$211.10$228.73

Year-by-year: MMC vs JNJ ($10,000, DRIP)

YearMMC PortfolioMMC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,066$365.91$10,592$272.30+$474.00MMC
2$12,543$702.73$11,289$357.73+$1.3KMMC
3$14,804$1,382.43$12,123$472.89+$2.7KMMC
4$18,672$2,831.59$13,141$629.86+$5.5KMMC
5$26,177$6,198.25$14,408$846.81+$11.8KMMC
6$43,090$15,081.12$16,021$1,151.60+$27.1KMMC
7$89,191$43,084.83$18,122$1,588.22+$71.1KMMC
8$250,208$154,773.33$20,930$2,228.20+$229.3KMMC
9$1,021,256$753,533.27$24,792$3,191.91+$996.5KMMC
10$6,430,560$5,337,816.49$30,274$4,689.40+$6.40MMMC

MMC vs JNJ: Complete Analysis 2026

MMCStock

Marsh & McLennan Companies, Inc., a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates in two segments, Risk and Insurance Services, and Consulting. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, catastrophe and financial modeling, and related advisory services; and insurance program management services. This segment serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth, and career consulting services and products; and specialized management, as well as economic and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.

Full MMC Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this MMC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MMC vs SCHDMMC vs JEPIMMC vs OMMC vs KOMMC vs MAINMMC vs ABBVMMC vs MRKMMC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.